Test Price
1,500 AED✅ Home Collection Available
Aldosterone/Renin Direct Ratio (Plasma) Test in Dubai | 1500 AED | DHA Licensed at DNA Labs UAE
Executive Summary & Core Metrics
Test Overview & Methodology
The Aldosterone/Renin Direct Ratio (Plasma) test is a first-line screening tool for primary aldosteronism, the most common endocrine cause of secondary hypertension. It measures simultaneous aldosterone and direct renin concentrations using CLIA technology, enabling accurate differentiation of adrenal disorders. This assay employs Direct Renin CLIA (μg/L) paired with Aldosterone CLIA (ng/dL), validated against LC-MS/MS reference standards for superior precision and reproducibility.
| Feature | DNA Labs UAE – Direct Renin CLIA | Standard Lab – Plasma Renin Activity (PRA) |
|---|---|---|
| Methodology | Direct Renin CLIA (μg/L) + Aldosterone CLIA (ng/dL), validated against LC-MS/MS | Plasma Renin Activity (PRA, ng/mL/hr) – indirect, lower specificity |
| Turnaround Time | Same-day report (Tue/Fri by 11 am) | 3–5 working days |
| Home Collection | VIP Phlebotomy with ISO-certified cold-chain transport | Limited or non-specialized logistics |
| Pre-analytical Control | Strict upright posture, EDTA plasma, frozen shipment – no freeze-thaw cycles | Variable posture adherence, may compromise ratio accuracy |
| Price | 1500 AED (Insurance eligible) | 1200–1800 AED (variable rate) |
Physician Insight & Safety Protocols
“As a DHA-licensed General Practitioner, I emphasize that the aldosterone/renin ratio serves as a screening parameter and must be interpreted within the full clinical context, including blood pressure trends, serum potassium levels, and medication history. Confirmatory suppression testing and adrenal imaging are required before any surgical or medical intervention. Patients should never alter antihypertensive therapy without explicit guidance from their treating physician.”
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Medication Safety Advisory
Critical Pre-Test Medication Management
Abrupt discontinuation of prescribed antihypertensives may precipitate a hypertensive crisis. Any medication adjustments, including withdrawal of ACE inhibitors, ARBs, diuretics, or beta-blockers, must be supervised by the prescribing clinician. Do not self-modify your treatment regimen.
Exclusion Criteria & Emergency Indicators
- Inability to maintain upright or ambulatory posture for a minimum of 2 hours before venipuncture.
- Confirmed hypersensitivity to EDTA or history of severe vasovagal response to blood draws.
- Current use of potassium-sparing diuretics, spironolactone, eplerenone, amiloride, or triamterene within the past 4 weeks without explicit clinical clearance.
- Use of adrenergic blockers, clonidine, methyldopa, NSAIDs, ACE inhibitors, ARBs, direct renin inhibitors, or dihydropyridine CCBs within the prior 2 weeks.
- Onset of acute chest pain, severe dyspnea, sudden visual disturbance, or neurologic deficit requires immediate emergency department evaluation.
* For patients with poorly controlled hypertension, alternative agents such as verapamil sustained-release, hydralazine, prazosin, doxazosin, or terazosin may be considered under medical supervision.
Patient FAQ & Clinical Guidance
1. What is the correct preparation for the aldosterone/renin ratio blood test?
Maintain an upright posture—standing or walking—for at least 2 hours immediately before sample collection. Follow your physician's instructions regarding temporary medication adjustments. Avoid high-sodium meals for 24 hours prior, and inform the phlebotomist of all current prescriptions.
2. Why does the direct renin method outperform plasma renin activity (PRA)?
Direct renin concentration measured by CLIA provides superior analytical sensitivity, better inter-laboratory standardization, and faster turnaround compared to the indirect PRA method. It eliminates variability from endogenous angiotensinogen and cryoactivation, yielding a more reliable aldosterone/renin ratio for primary aldosteronism screening.
3. What clinical significance does an elevated aldosterone/renin ratio carry?
A raised ratio typically indicates primary aldosteronism, a condition marked by autonomous aldosterone secretion from the adrenal glands, driving hypertension and potential hypokalemia. Confirmatory testing—such as saline infusion or captopril challenge—and adrenal imaging are essential to distinguish unilateral adenoma from bilateral hyperplasia before treatment planning.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Governance
This service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Laboratory operations are ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139). All diagnostic results must be interpreted in conjunction with a complete medical history; no single laboratory value replaces a comprehensive clinical evaluation.
Clinical & Logistical Metadata
| Test Name | Aldosterone/Renin Direct Ratio (Plasma) |
| Price (AED) | 1500 AED |
| Turnaround Time | Same-day report (Tuesday and Friday by 11:00 AM) |
| Sample Type / Matrix | Plasma (EDTA) |
| Methodology Used | Direct Renin CLIA (μg/L) + Aldosterone CLIA (ng/dL), validated against LC-MS/MS |
| ICD-10-CM Code | E26.0 |
| LOINC Code | 45336-9 |
| DHA Facility License & Laboratory Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians